UKÂ lowers Covid-19 alert level
The UK’s chief medical officers have agreed that the Covid-19 threat level should be lowered one notch to "epidemic is in general circulation" from "transmission is high or...
DHSC releases second drug price concession list for June
The Department of Health and Social Care (DHSC) has released second drug price concession list for the month of June, 2020 on Thursday (June...
UK ditches Covid-19 app model to use Google-Apple system
Britain will switch to Apple and Google technology for its Covid-19 test-and-trace app, ditching its homegrown system which was not working well enough on Apple's...
Covid-19 test and trace system crosses 87K in England
The number of contacts of positive Covid-19 cases reached by England's test and trace system in its first two weeks of operation was 87,639, Britain's...
Evorel products may witness supply disruptions
Theramex, the manufacturer of Evorel products, said there will be an intermittent supply shortages of Evorel 75, Evorel Conti in June due to rising demand.
The...
Well unveils initiative to asses risks to BAME staff
Well Pharmacy has joined forces with senior academic and pharmacist Professor Mahendra Patel to assess risks to its black Asian, and minority ethnic (BAME)...
Gidley’s apology for ‘insensitive’ comments on BAME discrimination sparks debate
RPS president Sandra Gidley has apologised for her ‘insensitive’ comments on discrimination faced by pharmacists from the BAME background.
The comment and apology have, however,...
Scheme to incentivise pharma giants to develop new generation of antibiotics
To help secure much-needed alternative treatment options for NHS patients, the UK government will be launching a pioneering scheme that incentivises pharmaceutical companies to...
Three year deal to pump £18.3m into Welsh pharmacies
Community pharmacies in Wales are to get an additional funding in excess of £18m by 2023 in a three-year settlement with the Welsh government.
Welsh...
RPS in England welcomes to second part of PHE report on impact of Covid-19 on BAME groups
The Royal Pharmaceutical Society (RPS) has welcomed the Public Health England report- 'Understanding the impact of Covid-19 on BAME groups'.
The PHE review of disparities...
Current Issue March 2024
